Author Correction: Super-Mendelian inheritance mediated by CRISPR–Cas9 in the female mouse germline

被引：0
|
作者：
Hannah A. Grunwald
Valentino M. Gantz
Gunnar Poplawski
Xiang-Ru S. Xu
Ethan Bier
Kimberly L. Cooper
机构：
[1] University of California,Division of Biological Sciences, Section of Cellular and Developmental Biology
[2] San Diego,Department of Neurosciences
[3] University of California,Tata Institute for Genetics and Society
[4] San Diego,Department of Medicine
[5] University of California,undefined
[6] San Diego,undefined
[7] National University of Singapore,undefined
来源：
Nature | 2020年 / 577卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码：E8 / E8
相关论文
共 50 条
  • [41] Publisher Correction: Structural basis for mismatch surveillance by CRISPR–Cas9
    Jack P. K. Bravo
    Mu-Sen Liu
    Grace N. Hibshman
    Tyler L. Dangerfield
    Kyungseok Jung
    Ryan S. McCool
    Kenneth A. Johnson
    David W. Taylor
    Nature, 2022, 604 (7904) : E10 - E10
  • [42] Benefits of Using the CRISPR/Cas9 System for the Correction of Genetic Mutations
    R. A. Sharipov
    M. A. Omarov
    A. R. Mulyukov
    A. I. Dybova
    E. T. Vyaseleva
    N. B. Kayumova
    A. Sh. Saitgalina
    K. R. Ententeev
    I. R. Iagafarov
    I. V. Kuserbaev
    E. A. Gubaeva
    Molecular Genetics, Microbiology and Virology, 2023, 38 : 137 - 142
  • [43] Correction of Fanconi Anemia Mutation Using the Crispr/Cas9 System
    Kawashima, Nozomu
    Okuno, Yusuke
    Sekiya, Yuko
    Wang, Xinan
    Narita, Atsushi
    Doisaki, Sayoko
    Kamei, Michi
    Nishio, Nobuhiro
    Muramatsu, Hideki
    Hama, Asahito
    Takahashi, Yoshiyuki
    Kojima, Seiji
    BLOOD, 2015, 126 (23)
  • [44] CRISPR/Cas9 induced deletion for the correction of the human dystrophin gene
    Duchene, B.
    Iyombe-Engembe, J-P
    Lo, M.
    Reichelt, P.
    Rousseau, J.
    Ouellet, D. L.
    Tremblay, J. P.
    HUMAN GENE THERAPY, 2017, 28 (12) : A54 - A54
  • [45] Novel protocol for highly efficient CRISPR/Cas9 mediated gene correction with reduced NHEJ rate
    Cullot, G.
    Boutin, J.
    Prat, F.
    Bierge, E.
    Lamrissi-Garcia, I.
    Guyonnet-Duperat, V.
    Prouzet-Mauleon, V.
    De Verneuil, H.
    Dabernat, S.
    Moreau-Gaudry, F.
    Bedel, A.
    HUMAN GENE THERAPY, 2017, 28 (12) : A54 - A55
  • [46] CRISPR–Cas9, CRISPRi and CRISPR-BEST-mediated genetic manipulation in streptomycetes
    Yaojun Tong
    Christopher M. Whitford
    Kai Blin
    Tue S. Jørgensen
    Tilmann Weber
    Sang Yup Lee
    Nature Protocols, 2020, 15 : 2470 - 2502
  • [47] CRISPR/Cas9 Mediated Deletion of the Uox Gene Generates a Mouse Model of Hyperuricemia with Multiple Complications
    Zeng, Linzi
    Shali, Shalaimaiti
    Gao, Yabiao
    Du, Xingchen
    Zhu, Xiaoxia
    Li, Lin
    Dai, Yuxiang
    Zhou, Ping
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024, 17 (06) : 1455 - 1465
  • [48] Gene editing in mouse zygotes using the CRISPR/Cas9 system
    Wefers, Benedikt
    Bashir, Sanum
    Rossius, Jana
    Wurst, Wolfgang
    Kuehn, Ralf
    METHODS, 2017, 121 : 55 - 67
  • [49] Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
    Gaetan Burgio
    Genome Biology, 19
  • [50] Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma
    Patil, Shruti V.
    Kaipa, Balasankara Reddy
    Ranshing, Sujata
    Sundaresan, Yogapriya
    Millar, J. Cameron
    Nagarajan, Bhavani
    Kiehlbauch, Charles
    Zhang, Qihong
    Jain, Ankur
    Searby, Charles C.
    Scheetz, Todd E.
    Clark, Abbot F.
    Sheffield, Val C.
    Zode, Gulab S.
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345